Real World Testing Results Report
QSmartCare
Executive Summary
This is the test report for CY 2025 real world testing for QSmartCare, a certified EHR solution from Magilen Enterprises Inc. This is the document to our CY 2025 real world test plan that describes our approach for conducting real world testing in CY 2025 and how the testing measures we employed.
Our findings show that QSmartCare certified EHR is working as it was certified as no errors or non-compliances were observed. We did make some adjustments and add in some compliance testing as several of our measures had metrics of “0” results because our clinician users do not perform the certified functionality in daily workflows.
For each of our CY 2025 Real World Testing Measures, we have recorded our results and findings. If any non-conformities or errors were encountered, we noted them. Our signed attestation of compliance with the real world testing requirements is on the following page.
General Information
Plan Report ID Number: 20240918mag
Developer Name: Magilen Enterprises, Inc
Product Name(s): QSmartCare
Version Number(s): 1.0
Certified Health IT Product List (CHPL) ID(S):
· 15.05.05.3098.MAGE.01.00.1.220127
· https://chpl.healthit.gov/#/listing/10803
Developer Real World Testing Page URL: https://qsmartcare.com/real-world-testing-documentation.html
Changes to Original Plan
Changes to the approach for Real World Testing that differ from what was outlined in the plan, are noted here
|
Summary of Change |
Reason for Change |
Impact |
|
170.315(g)(7,9) API |
We did not have any request for use our API functionality in CY 2025 so our metrics for this measure are 0. We created C-CDA test patients and validated that we were able to view the patient information via API using the Postman tool. We were able to successfully confirm our API works in a production setting |
No Impact |
|
170 315(g)(10) Standardized API for Patient and Population Service |
We did not have any request for use our API functionality in CY 2025 so our metrics for this measure are 0. We created C-CDA test patients and validated that we were able to view the patient information via API using the Postman tool. We were able to successfully confirm our API works in a production setting |
No Impact |
Withdrawn Products
No products have been withdrawn
Summary of Testing Methods and Key Findings
We have used audit logs and database queries to get the required metrics for this Real World Testing. All the operations mentioned in our RWT plan are tested. Data was collected from 1 Jan 2025 to 31 Dec 2025. We have collected data based on the usage. All the functionalities worked as excepted, and the outcomes are documented below. In our testing, we did confirm that our users do not utilize g7, g9, g10 measures. Our EHR is only used by one healthcare provider (ourselves) and our provider have not used Direct to send/receive C-CDAs thus far. During our testing, we did not discover any errors or criteria non-conformities.
STANDARDS UPDATES (INCLUDING STANDARDS VERSION ADVANCEMENT PROCESS (SVAP)
[✓ ] Yes, I have products certified with voluntary SVAP standards. (If yes, please complete the table below.
[ ] No, none of my products include these voluntary standards.
SVAP Standards Updates
|
Standard (and version) |
a) 170.205(a)(5) HL7® CDA R2 Implementation Guide: C-CDA Templates for Clinical Notes R2.1 Companion Guide, Release 3-US Realm, May 2022 for g9 |
|
Updated certification criteria and associated product |
G9 & G10 |
|
Health IT Module CHPL ID |
15.05.05.3098.MAGE.01.00.1.220127 |
|
Method used for standard update |
SVAP |
|
Date of ONC-ACB notification for g9 |
11/16/2022 |
|
Date of ONC-ACB notification for g10 |
11/21/2022 |
|
Date of customer notification (SVAP only) for g9 |
12/25/2022 |
|
Date of customer notification (SVAP only) for g10 |
N/A |
|
Conformance Measure |
Measure 5 for g9 |
Care Settings
Facilities:Inpatient
Speciality:Wound Care
Metrics and Outcome
|
Measure |
Criteria |
Replied Upon Software |
Outcomes |
Challenges Encountered |
|
5 |
170.315(g)(7, 9) API |
|
We did not have any developers use our API functionality in CY 2025 so our metrics for this measure are 0. We created C-CDA test patients and validated that we were able to view the patient information via API using the Postman tool. We were able to successfully confirm our API works in a production setting |
NA |
|
15 |
170 315(g)(10) Standardized API for Patient and Population Service |
|
We did not have any request for use our API functionality in CY 2025 so our metrics for this measure are 0. We created C-CDA test patients and validated that we were able to view the patient information via API using the Postman tool. We were able to successfully confirm our API works in a production setting |
NA |
Key Milestones
|
Key Milestones |
Care Setting |
Data Timeframe |
|
Released of documentation for the Real-World Testing to be provided to authorized representatives and providers. |
Facilities: Inpatient |
October 2024 |
|
Identified the user participants to participate in the test plan |
Facilities: Inpatient |
December 2024 |
|
Confirmed that participants can log into their accounts and are ready to start the RWT test plan |
Facilities: Inpatient |
February 2025 |
|
Followed up with providers and authorized representatives regularly to understand any issues arising with the data collection. |
Facilities: Inpatient |
March 2025 |
|
Ended Real-World Testing period/final collection of all data for analysis. |
Facilities: Inpatient |
June 2025 |
|
Real World Testing data analysis and generation of report. |
Facilities: Inpatient |
August 2025 |
|
Submitted Real World Testing report to ACB (per their instructions) |
Facilities: Inpatient |
January 2026 |
Developer Attestation
This Real World Testing results is complete with all required elements, including measures that Address all certification criteria and care settings. All information in these results is up to date and fully addresses the health IT developer’s Real World Testing requirements.
Authorized Representative Name: Steven Magilen
Authorized Representative Email: smagilen@magilen.com
Authorized Representative Phone: (305) 466-9988
Authorized Representative Signature:
Date: 01/09/2026